Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Grants
$275k
1 grant · CORDIS
Backers
1
Y Combinator
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 15, 2023 Won a grant $275k · CORDIS Jan 2022 Went through Y Combinator
Funding rounds
RoundDateAmountInvestorsSource
Grant Aug 2023 $275k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Alia therapeuticsSeed $4.8M · 3 yr ago · 11-50 employees
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
HarborSite11-50 employees
HarborSite pioneers programmable gene insertion technology using engineered recombinase enzymes to cure genetic diseases and unlock gene…
Cell and Gene Therapy. Cure Genetics Committed to the development of gene and cell therapy for oncology and genetic diseases Cure Genetics…
ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
Addition TherapeuticsVenture round $100M · 10 mo ago · Founded 2021 · 4 roles
We're on a mission to fulfill the promise of genetic medicine for all patients. At Addition, we are advancing a pipeline of therapeutics to…
Precision BioSciencesVenture round $88.1M · 8 yr ago
ARCUS Genome Editing. At Precision BioSciences, we are using our novel ARCUS genome-editing technology to develop a new class of medicines…

Overview

Uncover Cures for Genetic Diseases in Children with Rosebud Biosciences.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco United States
HQ
10-50 est. staff

Financials

Total raised
$275k
Latest round
Grant
Funding rounds
1
Funding rounds
Round Announced Amount
Grant 2023 $275k Details